Priority Review Vouchers Post Lower Average Approval Times Than Priority NMEs

 
• By Bridget Silverman
  
Sand running through the bulbs of an hourglass measuring the passing time in a countdown to a deadline, on a dark background with copy space.
Approval with a PRV occurs on average 3.9 months quicker than for an NME or novel biologic receiving standard review.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards